Lipoprotein(a) [Lp(a)] as a Causal Factor for ASCVD and Calcific Aortic Valve Disease
Japan’s medical community has issued a definitive expert consensus statement regarding Lipoprotein(a)—known widely as Lp(a)—identifying it as a genetically determined causal factor for atherosclerotic cardiovascular disease and calcific aortic valve … Read More